UBS lowered the firm’s price target on Northrop Grumman (NOC) to $571 from $583 and keeps a Buy rating on the shares. The ramp to 2025 guidance looks tough, but Northrop Grumman’s record backlog represents a longer term opportunity, the analyst tells investors in a research note.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Northrop Grumman price target lowered to $550 from $600 at Truist
- Northrop Grumman price target lowered to $540 from $557 at Susquehanna
- Northrop Grumman price target lowered to $550 from $585 at BofA
- Northrop Grumman Reports Q1 2025 Financial Results
- Northrop Grumman’s Earnings Call: Achievements and Challenges